PLA2R1 and inflammatory bowel disease: Another observation is that all four genome-wide significant risk loci (PLA2R1, IRF4, NFKB1, and HLA) exhibit highly pleiotropic effects and all four lead SNPs have a concordant effect on the risk of inflammatory bowel disease (IBD).